Criterion Capital Advisors, LLC Bio Rad Laboratories, Inc. Transaction History
Criterion Capital Advisors, LLC
- $159 Billion
- Q3 2024
A detailed history of Criterion Capital Advisors, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Criterion Capital Advisors, LLC holds 27 shares of BIO stock, worth $8,865. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27
Previous 27
-0.0%
Holding current value
$8,865
Previous $7.37 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
456Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$626 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$509 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$428 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$357 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$234 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.09B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...